{
  "guideline": {
    "id": "PA166104843",
    "name": "Annotation of FDA Label for celecoxib and CYP2C9",
    "source": "FDA",
    "version": 32,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166104843",
    "relatedChemicals": [
      {
        "id": "PA448871",
        "name": "celecoxib",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA126",
        "name": "cytochrome P450 family 2 subfamily C member 9",
        "symbol": "CYP2C9"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166311962",
      "name": "Recommendation Annotation PA166311962",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA448871",
          "name": "celecoxib",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216161,
        "html": "<p>&quot;Poor Metabolizers of CYP2C9 Substrates: Consider a dose reduction by 50% (or alternative management for JRA) in patients who are known or suspected to be CYP2C9 poor metabolizers.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2C9": "0.5"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311961",
      "name": "Recommendation Annotation PA166311961",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA448871",
          "name": "celecoxib",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216160,
        "html": "<p>&quot;Poor Metabolizers of CYP2C9 Substrates: Consider a dose reduction by 50% (or alternative management for JRA) in patients who are known or suspected to be CYP2C9 poor metabolizers.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2C9": "0.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product CELEBREX (Celecoxib), NDA020998, Aphena Pharma Solutions - Tennessee, LLC",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020998"
    }
  ],
  "version": "2024-02-29-20-19"
}